ArticleMedComm2026

Preclinical Efficacy and Safety Study of a Novel Dermal Fibroblast Modulating Drug, SLI-F06, in Cutaneous Wound Healing.

Zhong Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.